Proteus Digital Health’s ingestible sensor, an adherence tool that’s been successfully tested before in patients with diabetes and heart failure, also has utility for those on psych meds, a study ...

Oracle has expanded its move into pharmaceutical innovation by investing an undisclosed “minor” sum in Proteus Digital Health, a company that has developed ingestible and wearable sensors. Proteus’ ...

Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month. That ...

Proteus (News - Alert) Biomedical recently announced European Union approval of its ingestible sensor and personal physiologic monitor system. The sensors are designed to be safe to swallow in order ...